Samsara Bio Capital, LLC Vista Gen Therapeutics, Inc. Transaction History

Samsara Bio Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.73 $429,996 - $845,333	-488,632 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.62 - $3.45 $639,185 - $841,675	-243,964 Reduced 33.3%	488,632 $1.34 Million
Q2 2021 Aug 17, 2021	SELL	$1.96 - $3.15 $2.15 Million - $3.46 Million	-1,098,894 Reduced 60.0%	732,596 $2.31 Million
Q1 2021 May 18, 2021	BUY	$1.89 - $2.96 $361,220 - $565,721	191,122 Added 11.65%	1,831,490 $3.9 Million
Q4 2020 Feb 17, 2021	BUY	$0.65 - $1.94 $1.07 Million - $3.18 Million	1,640,368 New	1,640,368 $0

27.1K

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $527M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Samsara Bio Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Samsara Bio Capital, LLC with notifications on news.